Newsletter Archive

  1. 09.10.26 -- Solving The Complexities of Rare Disease Clinical Development 9/10/2026

    09/10/26 Life Science Leader Newsletter

  2. 09.09.26 -- Five Of The Most Useful Transformations In Modern Organic Synthesis 9/9/2026

    09/09/26 Life Science Leader Newsletter

  3. 09.06.26 -- Stopping A Drug Development Program Sometimes Creates More Value Than Continuing 9/6/2026
    09/06/26 Life Science Leader Newsletter
  4. 09.04.26 -- Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil 9/4/2026

    09/04/26 Life Science Leader Newsletter

  5. 09.04.26 -- New Podcast Episodes: Fixing AAV Recovery, Cell Therapy Advances, Reimagining Solid Tumor Immunotherapy 9/4/2026
    09/04/26 Life Science Leader Newsletter
  6. 09.04.26 -- Compounding Progress: The Engine Behind Faster Biologics Development 9/4/2026

    09/04/26 Life Science Leader Newsletter

  7. 09.03.26 -- Finding The Right Trial Model For Better Study Outcomes 9/3/2026

    09/03/26 Life Science Leader Newsletter

  8. 09.02.26 -- When Timelines Trump Science In Neuropsychiatric Trials 9/2/2026

    09/02/26 Life Science Leader Newsletter

  9. 08.31.26 -- Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction 8/31/2026

    08/31/26 Life Science Leader Newsletter

  10. 08.28.26 -- How Point-Of-Need Execution Protects Ocular Endpoints 8/28/2026
    08/28/26 Life Science Leader Newsletter